Annovis Bio, Inc. (ANVS) Misses Q3 EPS by 6c

Annovis Bio, Inc. (NYSE: ANVS) reported Q3 EPS of ($0.37), $0.06 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Annovis Bio, Inc. (ANVS) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Northrop Grumman wins two U.S. defense contracts worth $38.7m